A Randomized Double-blind Clinical Study for the Effect of Qingzhi Huayu Prescription on SDLDL-C/LDL-C in Patients With Coronary Heart Disease
- Conditions
- Coronary Atherosclerotic Heart Disease
- Registration Number
- ITMCTR1900002589
- Lead Sponsor
- Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Objectives: patients have coronary atherosclerotic heart disease (CAD) with high sdLDL-C.
Selection criteria:
1) Age between 18 and 80 (including 18 and 80);
2) Gender is not limited;
3) Coronary angiography showed that the stenosis of any coronary artery exceeded 50%.
4) sdLDL-C (>= 52.6mg/dL)
5) Patients willing to receive atorvastatin treatment and Traditional Chinese Medicine treatment.
1) History of statin-related liver lesions and/or myopathy;
2) Patients with malignant tumors (excluding those cured);
3) Patients with serious diseases of heart, lung, kidney, brain and blood;
4) Patients with severe neurological and psychiatric disorders (such as epilepsy, depression, mania, seizures, schizophrenia, etc.);
5) Pregnant women and lactating women or those who have pregnancy plans and are unwilling to contracept during the study period;
6) Participate in other clinical researchers at the same time;
7) Researchers think that it is not suitable for patients to participate in this study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method sdLDL-C;
- Secondary Outcome Measures
Name Time Method TG;HDL-C;TC;LDL-C;